| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | MANNKIND CORP. | 22,317 | 36,000 | 0.03% | ||
| 102 | SYNTA PHARMACEUTICALS CORP | 102,742 | 25,000 | 0.02% | ||
| 103 | GENERAL MOLY INC | 56,160 | 19,000 | 0.01% | ||
| 104 | Apricus Biosciences, Inc. | 25,000 | 15,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001663138-16-000002, filed 2016.04.18).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
